Provided by Tiger Trade Technology Pte. Ltd.

Valneva SE

9.49
+0.16001.71%
Post-market: 9.490.00000.00%16:00 EST
Volume:47.50K
Turnover:448.32K
Market Cap:819.74M
PE:-6.65
High:9.63
Open:9.44
Low:9.35
Close:9.33
52wk High:12.25
52wk Low:5.43
Shares:86.38M
Float Shares:64.58M
Volume Ratio:4.46
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4273
EPS(LYR):-0.1740
ROE:-55.53%
ROA:-9.64%
PB:4.61
PE(LYR):-54.53

Loading ...

BUZZ-Valneva jumps on 'attractive' risk/reward profile ahead of vaccine's phase 3 results

Reuters
·
Feb 04

Valneva, Instituto Butantan Start Pilot Program for Chikungunya Vaccine in Brazil

MT Newswires Live
·
Feb 03

Valneva Steps Back From US Approval Bid For Chikungunya Vaccine

Benzinga_recent_news
·
Jan 21

Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga
·
Jan 20

Valneva withdraws BLA, IND application for Ixchiq in U.S.

TIPRANKS
·
Jan 20

Valneva SE Terminates Vaccine Deal with Serum Institute

MT Newswires Live
·
Jan 01

First Berlin Equity Research Raises Valneva SE Price Target to €6.80

Reuters
·
Dec 08, 2025

Analysts Offer Insights on Healthcare Companies: Valneva (VALN) and Neurocrine (NBIX)

TIPRANKS
·
Nov 28, 2025

Valneva to Consolidate French Operations in Lyon

MT Newswires Live
·
Nov 27, 2025

Stock Track | Valneva SE Soars 7.55% on Positive Lyme Disease Vaccine Trial Data

Stock Track
·
Nov 27, 2025

Stock Track | Valneva SE Soars 7.55% Intraday on Positive Lyme Disease Vaccine Data

Stock Track
·
Nov 27, 2025

Valneva Shares Rise on Positive Data from Lyme Disease Vaccine Study

Dow Jones
·
Nov 26, 2025

Guggenheim Sticks to Its Buy Rating for Valneva (VALN)

TIPRANKS
·
Nov 21, 2025

Valneva Nine Months 2025 EPS €(0.39) Down From €0.17 YoY, Revenue €126.97M Up From €116.6M YoY

Benzinga
·
Nov 20, 2025

Press Release: Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates

Dow Jones
·
Nov 20, 2025

A Lyme Disease Vaccine's Final Test Results Could Appear By Yearend. -- Barrons.com

Dow Jones
·
Sep 10, 2025

Valneva Is Maintained at Buy by Guggenheim

Dow Jones
·
Sep 08, 2025

Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July

Benzinga
·
Aug 26, 2025

Top Midday Decliners

MT Newswires Live
·
Aug 26, 2025

Valneva Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 26, 2025